Literature DB >> 27801688

Current and effective advantages of femto phacoemulsification.

Ashvin Agarwal1, Soosan Jacob.   

Abstract

PURPOSE OF REVIEW: The purpose is to review the current and effective advantages of femtosecond laser-assisted cataract surgery (FLACS). RECENT
FINDINGS: FLACS has advantages over manual phacoemulsification in its precision, and predictability and may be especially advantageous in difficult situations such as shallow anterior chamber, subluxated cataracts, white cataracts, and so on. However, the femtosecond capsulorhexis may not be as strong as a manual rhexis. Laser-induced miosis is also a potential disadvantage.
SUMMARY: There may be increased surgeon confidence and patient satisfaction with FLACS and it may be friendlier to the internal structures of the eye. However, it is not superior to manual phacoemulsification in terms of primary outcomes such as visual and refractive outcomes or overall complications. Further refinements in technology may be needed to give it distinct advantages over manual phacoemulsification and to make it the norm in cataract surgery.

Entities:  

Mesh:

Year:  2017        PMID: 27801688     DOI: 10.1097/ICU.0000000000000333

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  13 in total

1.  [Application of femtosecond laser technology in the management of subluxated lens].

Authors:  Ruihong Ju; Yun Chen; Wei Yang; Mansha He; Yuanhong Pan; Zheming Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-07-30

2.  Two-Year Follow-Up of Clinical Efficacy of Femtosecond Laser, Modified Capsular Tension Ring, and Iris Hook-Assisted Surgical Treatment of Lens Subluxation in Patients with Elevated Intraocular Pressure.

Authors:  Chao Wang; Yuhua Rui; Yi Zhou; Tu Hu; Xiaobo Xia; Jian Jiang
Journal:  J Ophthalmol       Date:  2022-05-09       Impact factor: 1.974

3.  Refractive Outcomes in Fuchs' Endothelial Corneal Dystrophy: Conventional and Femtosecond Laser-Assisted Cataract Surgery.

Authors:  Ellen H Koo; Vikram Paranjpe; William J Feuer; Patrice J Persad; Kendall E Donaldson
Journal:  Clin Ophthalmol       Date:  2021-08-12

4.  Intra and post-operative complications observed with femtosecond laser-assisted cataract surgery versus conventional phacoemulsification surgery: a systematic review and meta-analysis.

Authors:  Jinhua Wang; Fanfan Su; Yong Wang; Yao Chen; Qiao Chen; Fen Li
Journal:  BMC Ophthalmol       Date:  2019-08-09       Impact factor: 2.209

5.  Comparison of optical quality and distinct macular thickness in femtosecond laser-assisted versus phacoemulsification cataract surgery.

Authors:  Yong Wang; Jinling Zhang; Miaomiao Qin; Jianguo Miao; Wei Chen; Yemeng Huang; Jian Wu; Yu Guan; Huaijin Guan
Journal:  BMC Ophthalmol       Date:  2020-02-01       Impact factor: 2.209

6.  Iris cyst after femtosecond laser-assisted cataract surgery: a case report.

Authors:  Po-Ying Wu; Meng-Hsien Wu; Chi-Cheng Wu; Chi-Chin Sun
Journal:  BMC Ophthalmol       Date:  2021-01-13       Impact factor: 2.209

7.  Femtosecond Laser-Assisted Cataract Surgery in Soft and Hard Nuclear Cataracts: A Comparison of Effective Phacoemulsification Time.

Authors:  Ahmed H Assaf; Mohamed G Aly; Rania G Zaki; Yasmine M Shaaban; Bassem F Aziz
Journal:  Clin Ophthalmol       Date:  2021-03-10

8.  Long-term visual field changes after femtosecond laser-assisted cataract surgery in glaucoma patients, case series.

Authors:  Daniela Alvarez-Ascencio; Carolina Prado-Larrea; Jesus Jimenez-Roman; Rafael Castañeda-Diez
Journal:  Am J Ophthalmol Case Rep       Date:  2021-07-09

9.  Corneal higher-order aberrations after cataract surgery: Manual phacoemulsification versus femtosecond-laser assisted technique.

Authors:  Dominika Pohlmann; Daniel Pilger; Eckart Bertelmann; Christoph von Sonnleithner
Journal:  Eur J Ophthalmol       Date:  2021-01-26       Impact factor: 2.597

10.  COVID-19 and cataract surgery backlog in Medicare beneficiaries.

Authors:  Shruti Aggarwal; Punya Jain; Amit Jain
Journal:  J Cataract Refract Surg       Date:  2020-11       Impact factor: 3.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.